Log in to save to my catalogue

Therapies for Chronic Spontaneous Urticaria: Present and Future Developments

Therapies for Chronic Spontaneous Urticaria: Present and Future Developments

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8bda43349f7a47e288745970099aba4d

Therapies for Chronic Spontaneous Urticaria: Present and Future Developments

About this item

Full title

Therapies for Chronic Spontaneous Urticaria: Present and Future Developments

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2024-11, Vol.17 (11), p.1499

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Chronic spontaneous urticaria (CSU) is a complex dermatological condition characterized by recurrent wheals and/or angioedema lasting for more than six weeks, significantly impairing patients' quality of life. According to European guidelines, the first step in treatment involves second-generation H1-antihistamines (sgAHs), which block peripheral H...

Alternative Titles

Full title

Therapies for Chronic Spontaneous Urticaria: Present and Future Developments

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8bda43349f7a47e288745970099aba4d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8bda43349f7a47e288745970099aba4d

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph17111499

How to access this item